SWOG clinical trial number
CTSU/NRG-GI004

Colorectal Cancer Metastatic dMMR/MSI-H Immuno-Therapy (COMMIT) Study: A Randomized Phase III Study of mFOLFOX6/Bevacizumab/Atezolizumab Combination Versus Single Agent Atezolizumab in the First-Line Treatment of Patients with Deficient DNA Mismatch Repair (dMMR)/Microsatellite Instability-High (MSI-H) Metastatic Colorectal Cancer

Open
Phase
Abbreviated Title
COMMIT
Participants
CTSU, ALL NATIONAL CLINICAL TRIALS NETWORK MEMBERS LISTED ON TITLE PAGE

Research committees

Gastrointestinal Cancer
Symptom Control and Quality of Life

Other Clinical Trials

S2205
SWOG Clinical Trial Number

ICE COMPRESS: Randomized Trial of Limb Cryocompression versus Continuous Compression Versus Low Cyclic Compression for the Prevention of Taxane-Induced Peripheral Neuroropathy

Research Committee(s)
Symptom Control and Quality of Life
Activated
03/16/2023
45% Accrual
Accrual
45%
Open
Phase
EAQ202
SWOG Clinical Trial Number

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

Research Committee(s)
Symptom Control and Quality of Life
Activated
10/28/2021
Open
Phase
S2013
SWOG Clinical Trial Number

Immune Checkpoint Inhibitor Toxicity (I-CHECKIT): A Prospective Observational Study

Research Committee(s)
Symptom Control and Quality of Life
Activated
08/16/2021
61% Accrual
Accrual
61%
Open
Phase